primary aldosteronism
Conditions
Interventions
two:adrenal arterial embolization
two:drug therapy
Sponsors
The First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Patients who have been diagnosed with primary aldosteronism; 2. Refuse drug treatment or drug treatment failure due to adverse reaction intolerance, or refuse adrenalectomy due to surgical risks, or have persistent aldosteronism after adrenalectomy, but not Adrenal insufficiency; 3. Patients with primary aldosteronism who voluntarily underwent adrenal artery embolization.
Exclusion criteria
Exclusion criteria: 1. History of serious contrast agent allergy; 2. Complication with severe liver diseases; 3. History of myocardial infarction and stent implantation within the past 3 months; 4. Renal insufficiency, serum creatinine >176 mmol/L; 5. Pregnancy or lactation; 6. Participation in another clinical trial in the past 3 months; 7. Any serious complications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| feritin;aldosterone;Blood pressure;Serum potassium;cardiac function;renal function;Body-mass index;MRI imaging features of epinephros;echocardiography;electrocardiogram;Fasting blood glucose;blood-lidpids;Local imaging of adrenaline(CXCR4); | — |
Countries
China
Contacts
Public ContactJing Chang
Outcome results
None listed